Study of Hepalatide in Chronic Hepatitis D(CHD) Patients

NCT05827146 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

23

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Hepatitis D Infection

Interventions

DRUG: Hepalatide
DRUG: Hepalatide Placebo

Sponsor

Shanghai HEP Pharmaceutical Co., Ltd.